RE:RE:RE:RE:RE:RE:Heading under $1It was in the Interim Report. II see now there is a new section "Income" and the subsequent events is cut off half way as is section 11 'comparative figures'. I emailed EATS to ask about that and Kelvin responded that they will provide an audited financial report up to Dec 31 at the end of the month. Subsequent Events from the Interim Report I downloaded several weeks ago:
Investments Subsequent to September 30, 2020, the Company has made the following investments:
Eat JUST, Inc. (“JUST”) is a private food technology company that produces plant-based foods, primarily operating in the United States. The Company has made a US$64,720 purchase of warrants in JUST and US$86,253 to exercise the warrants.
TurtleTree Labs Ptd Ltd. (“TurtleTree”) believes it is one of the first biotech companies in the world with the ability to create milk from any mammal. The Company has made a US$150,000 purchase of a SAFE note in TurtleTree.
SingCell TX Pte Ltd. (“SingCell”) is building a scalable clean meat manufacturing platform in Singapore to enable global alternative meat companies address APAC and global markets. The Company has made a US$113,878 purchase of convertible notes in SingCell.
Zoglo’s Incredible Food Corp is a leading company offering kosher, plant-based products. The Company participated in a $50,000 private placement.
Plant Power Restaurant Group LLC is known as an innovator in the quick service restaurant field which offers 100% plant-based and biodegradable packaging. The Company has made US$250,000 private placement.
Sire Bioscience Inc. is a life sciences company focused on the cultivation, production and sale of industrial hemp. the Company has made a $50,000 private placement. On November 16, 2020, the Company shares were approved for listing on the Canadian Securities Exchange and is classified as an investment issuer and commenced trading on November 17, 2020 under the trading symbol “EATS”).
Subsequent to September 30, 2020, the Company granted an aggregate of 2,960,000 stock options to directors, officers and consultants. On November 17, 2020, 3,362,640 special warrants were converted into 3,362,640 common shares of the Company. Subsequent to September 30, 2020, 10,794,857 share purchase warrants were exercised for total proceeds of $584,229.